ACON News

Form 8-K

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Echo Lake Capital Offers To Acquire Aclarion Inc.

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan